What do Trump’s tariffs on pharmaceuticals mean for the NHS?

What do Trump’s tariffs on pharmaceuticals mean for the NHS?

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports

Race to stop Trump tariffs hitting British medicine industry

Click here for a PDF of this post. Lord Mandelson, the UK ambassador to Washington, is ‘very focused’ on winning a reprieve for the multibillion-pound sector amid warnings patients could suffer Lord Mandelson, British Ambassador to the United States, is in a tearing hurry to protect the profits of the British biotech industry whose epicenter is The Pirbright Institute where Coronavirus was secretly invented with funding from DARPA, The Gates Fou…

Starmer must act now to protect NHS from Trump pharma tariffs

Starmer must make a deal to avoid Trump’s pharma tariffs or risk a major hit to the NHS and the UK’s leading pharmaceutical industry, write Ben Ramanauskas and Sean Phillips Last week, President Trump warned of “a major tariff”: up to 25 per cent on pharmaceutical products entering the United States. Currently, there is an exemption for pharmaceuticals on the baseline 10 per cent tariffs for goods coming into the US, but the President said that …

AAM comments on Section 232 investigation on pharmaceuticals

AAM said tariffs will exacerbate drug shortages that hinder patient access today.

US tariffs could drastically break down German pharmaceutical exports. A study shows how serious possible consequences would be.

Deloitte [Newsroom]Munich (ots) - - Exports to the USA could fall by up to 13 billion euros in the medium term. - High dependence of German companies on the world's largest pharmaceutical market USA - Compensation by other sales markets hardly possible The ... Continue reading here...Original content of: Deloitte, news transmitted by currently